QQQ   305.24 (+0.32%)
AAPL   122.57 (-0.30%)
MSFT   214.31 (+0.03%)
FB   281.00 (-0.30%)
GOOGL   1,827.03 (+0.28%)
AMZN   3,173.73 (-0.41%)
TSLA   591.39 (-0.34%)
NVDA   541.70 (+1.09%)
BABA   267.48 (+0.21%)
CGC   28.83 (+0.70%)
GE   10.69 (+0.85%)
MU   73.59 (+5.28%)
AMD   93.74 (+1.55%)
T   29.54 (+1.06%)
NIO   43.06 (-5.05%)
F   9.40 (+2.06%)
ACB   11.60 (+3.20%)
BA   234.43 (-1.17%)
NFLX   498.88 (+0.27%)
GILD   61.36 (+0.82%)
DIS   153.08 (-0.10%)
QQQ   305.24 (+0.32%)
AAPL   122.57 (-0.30%)
MSFT   214.31 (+0.03%)
FB   281.00 (-0.30%)
GOOGL   1,827.03 (+0.28%)
AMZN   3,173.73 (-0.41%)
TSLA   591.39 (-0.34%)
NVDA   541.70 (+1.09%)
BABA   267.48 (+0.21%)
CGC   28.83 (+0.70%)
GE   10.69 (+0.85%)
MU   73.59 (+5.28%)
AMD   93.74 (+1.55%)
T   29.54 (+1.06%)
NIO   43.06 (-5.05%)
F   9.40 (+2.06%)
ACB   11.60 (+3.20%)
BA   234.43 (-1.17%)
NFLX   498.88 (+0.27%)
GILD   61.36 (+0.82%)
DIS   153.08 (-0.10%)
QQQ   305.24 (+0.32%)
AAPL   122.57 (-0.30%)
MSFT   214.31 (+0.03%)
FB   281.00 (-0.30%)
GOOGL   1,827.03 (+0.28%)
AMZN   3,173.73 (-0.41%)
TSLA   591.39 (-0.34%)
NVDA   541.70 (+1.09%)
BABA   267.48 (+0.21%)
CGC   28.83 (+0.70%)
GE   10.69 (+0.85%)
MU   73.59 (+5.28%)
AMD   93.74 (+1.55%)
T   29.54 (+1.06%)
NIO   43.06 (-5.05%)
F   9.40 (+2.06%)
ACB   11.60 (+3.20%)
BA   234.43 (-1.17%)
NFLX   498.88 (+0.27%)
GILD   61.36 (+0.82%)
DIS   153.08 (-0.10%)
QQQ   305.24 (+0.32%)
AAPL   122.57 (-0.30%)
MSFT   214.31 (+0.03%)
FB   281.00 (-0.30%)
GOOGL   1,827.03 (+0.28%)
AMZN   3,173.73 (-0.41%)
TSLA   591.39 (-0.34%)
NVDA   541.70 (+1.09%)
BABA   267.48 (+0.21%)
CGC   28.83 (+0.70%)
GE   10.69 (+0.85%)
MU   73.59 (+5.28%)
AMD   93.74 (+1.55%)
T   29.54 (+1.06%)
NIO   43.06 (-5.05%)
F   9.40 (+2.06%)
ACB   11.60 (+3.20%)
BA   234.43 (-1.17%)
NFLX   498.88 (+0.27%)
GILD   61.36 (+0.82%)
DIS   153.08 (-0.10%)
Log in
NASDAQ:REGN

Regeneron Pharmaceuticals SEC Filings & 10K Form

$498.78
-0.06 (-0.01 %)
(As of 12/4/2020 11:40 AM ET)
Add
Compare
Today's Range
$495.49
Now: $498.78
$503.80
50-Day Range
$505.13
MA: $554.64
$600.82
52-Week Range
$328.13
Now: $498.78
$664.64
Volume16,845 shs
Average Volume1.12 million shs
Market Capitalization$53.22 billion
P/E Ratio19.31
Dividend YieldN/A
Beta0.51

SEC Filings

Regeneron Pharmaceuticals (NASDAQ:REGN) SEC Filings

DateFilerForm TypeView
12/02/2020
3:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:02 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
4:57 PM
COLES N ANTHONY (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
6:48 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:32 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
4:22 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
3:02 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:09 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:07 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:13 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:01 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:00 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:18 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:37 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:36 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:35 PM
POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:23 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:21 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:14 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:13 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
4:19 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:47 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2020
5:00 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:02 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2020
3:32 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
8:37 PM
Regeneron Pharmaceuticals (Filer)
Form 424B5
08/07/2020
3:48 PM
Regeneron Pharmaceuticals (Subject)
Form FWP
08/07/2020
8:27 AM
Regeneron Pharmaceuticals (Filer)
Form 424B3
08/05/2020
4:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:07 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
6:36 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2020
6:15 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2020
3:31 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
3:30 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
3:51 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
3:51 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2020
8:40 AM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
07/14/2020
3:17 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2020
3:29 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
3:16 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2020
3:14 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2020
6:28 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
3:02 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
3:08 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:03 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:10 PM
Regeneron Pharmaceuticals (Subject)
Sanofi (Filed by)
Form SC 13D/A
06/16/2020
3:33 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
3:01 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
5:45 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
9:13 AM
FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G
06/08/2020
7:47 AM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
05/28/2020
2:50 PM
Regeneron Pharmaceuticals (Filer)
Form 424B3
05/26/2020
5:16 AM
Regeneron Pharmaceuticals (Filer)
Form 424B3
05/26/2020
5:11 AM
Regeneron Pharmaceuticals (Subject)
Sanofi (Filed by)
Form FWP
05/26/2020
5:08 AM
Regeneron Pharmaceuticals (Subject)
Form FWP
05/22/2020
5:21 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
5:21 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
8:01 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
8:00 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:04 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
5:22 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2020
6:51 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2020
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2020
6:29 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2020
6:27 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/20/2020
6:26 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2020
6:23 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2020
3:02 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2020
5:06 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2020
3:50 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
3:49 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
5:49 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
3:12 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
5:14 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:10 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
3:45 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2020
8:04 AM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2020
6:33 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
4:06 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
8:14 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
3:07 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
3:05 PM
POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
5:03 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
4:43 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:44 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:41 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:38 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2019
3:08 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:07 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:06 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:03 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
4:02 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
6:47 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
12:58 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
09/12/2019
4:00 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
6:55 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.